Vyome Therapeutics Listed
Clinical-stage specialty biopharmaceutical company developing novel medicines for skin/immuno-inflammatory diseases caused by resistant microbes (dandruff, resistant acne, fungal and bacterial skin infections), using its proprietary DARTs and MRT drug platforms. Founded in New Delhi (~2010) and backed across five rounds (2010-2019) by Navam Capital, IndoUS Venture Partners/Kalaari Capital, Sabre Partners, Aarin Capital, Perceptive Advisors, Romulus Capital and Iron Pillar. Restructured…
Vyome Therapeutics: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 3 Jan 2019 | Series D | $22 Mn | Iron Pillar Kalaari Capital Perceptive Advisors Romulus Capital | source |
| 22 Aug 2016 | Series C | $14 Mn | Perceptive Advisors Romulus Capital Aarin Capital Kalaari Capital Sabre Partners | source |
| 12 Aug 2014 | Series B | $8 Mn | Sabre Partners Aarin Capital Kalaari Capital | source |
| 12 Sep 2012 | Series A | ₹18.5 Cr | IndoUS Venture Partners Aarin Capital Navam Capital | source |
| 2 Nov 2010 | Seed | $1 Mn | Navam Capital | source |
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 29 Sep 2025 | Vyome Therapeutics | Oculo, Inc. | Undisclosed | source |
News on Vyome Therapeutics
No coverage of Vyome Therapeutics linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on Vyome Therapeutics
Who founded Vyome Therapeutics?
Vyome Therapeutics was founded by Dr. Shiladitya Sengupta, Dr. Rajesh Gokhale, Venkateswarlu Nelabhotla (N. Venkat), Rajiv Mantri in 2010.
How much funding has Vyome Therapeutics raised?
Vyome Therapeutics has raised $48.34 Mn across 5 tracked funding round(s), most recently on 2019-01-03. Figures are compiled from cited public sources.
Who are the investors in Vyome Therapeutics?
Investors in Vyome Therapeutics include Iron Pillar, Kalaari Capital, Perceptive Advisors, Romulus Capital, Aarin Capital, Sabre Partners.
What does Vyome Therapeutics do?
Clinical-stage specialty biopharmaceutical company developing novel medicines for skin/immuno-inflammatory diseases caused by resistant microbes (dandruff, resistant acne, fungal and bacterial skin infections), using its proprietary DARTs and MRT drug platforms. Founded in New Delhi (~2010) and backed across five rounds (2010-2019) by Navam Capital, IndoUS…
Where is Vyome Therapeutics headquartered?
Vyome Therapeutics is headquartered in Cambridge, Massachusetts, India.
What is Vyome Therapeutics's business model?
Vyome Therapeutics's core value proposition centers on Novel medicines for microbial-resistant skin diseases.
How does Vyome Therapeutics make money?
Vyome Therapeutics's cited revenue streams include Product sales to marketing partner, Royalties on licensed/marketed products, Service / agent fee revenue, Total reported revenue (quarterly).